Literature DB >> 12387893

PIAS3 induces SUMO-1 modification and transcriptional repression of IRF-1.

Koji Nakagawa1, Hideyoshi Yokosawa.   

Abstract

Interferon regulatory factor-1 (IRF-1) is a transcriptional activator that is involved in interferon response, regulation of cell growth and oncogenesis. To try to identify the molecules that regulate the function of IRF-1, we performed yeast two-hybrid screening and isolated protein inhibitor of activated STAT3 (PIAS3) as an IRF-1-binding protein. This protein was also found to bind with small ubiquitin-related modifier-1 (SUMO-1) and ubiquitin-conjugating enzyme 9, an E2 in the SUMO-1-conjugating system. Co-expression of PIAS3 induced SUMO-1 modification of IRF-1 in a RING finger domain-dependent manner and also repressed transcriptional activity of IRF-1. Thus, PIAS3 functions as a SUMO-1 ligase for IRF-1 and also as a repressor of IRF-1 transcriptional activity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12387893     DOI: 10.1016/s0014-5793(02)03486-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  34 in total

Review 1.  IRF7: activation, regulation, modification and function.

Authors:  S Ning; J S Pagano; G N Barber
Journal:  Genes Immun       Date:  2011-04-14       Impact factor: 2.676

2.  Virus infection triggers SUMOylation of IRF3 and IRF7, leading to the negative regulation of type I interferon gene expression.

Authors:  Toru Kubota; Mayumi Matsuoka; Tsung-Hsien Chang; Prafullakumar Tailor; Tsuguo Sasaki; Masato Tashiro; Atsushi Kato; Keiko Ozato
Journal:  J Biol Chem       Date:  2008-07-17       Impact factor: 5.157

3.  The SUMO ligase PIAS1 regulates UV-induced apoptosis by recruiting Daxx to SUMOylated foci.

Authors:  Raghavi Sudharsan; Yoshiaki Azuma
Journal:  J Cell Sci       Date:  2012-09-12       Impact factor: 5.285

4.  PIAS3 negatively regulates RANKL-mediated osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblasts.

Authors:  Tomohiro Hikata; Hironari Takaishi; Jiro Takito; Akihiro Hakozaki; Mitsuru Furukawa; Shinichi Uchikawa; Tokuhiro Kimura; Yasunori Okada; Masahito Matsumoto; Akihiko Yoshimura; Riko Nishimura; Sakamuri V Reddy; Hiroshi Asahara; Yoshiaki Toyama
Journal:  Blood       Date:  2008-10-24       Impact factor: 22.113

5.  The association and nuclear translocation of the PIAS3-STAT3 complex is ligand and time dependent.

Authors:  Snehal Dabir; Amy Kluge; Afshin Dowlati
Journal:  Mol Cancer Res       Date:  2009-11-10       Impact factor: 5.852

6.  Specific and covalent targeting of conjugating and deconjugating enzymes of ubiquitin-like proteins.

Authors:  Joris Hemelaar; Anna Borodovsky; Benedikt M Kessler; David Reverter; Julie Cook; Nagamallesawari Kolli; Tudev Gan-Erdene; Keith D Wilkinson; Grace Gill; Christopher D Lima; Hidde L Ploegh; Huib Ovaa
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

7.  Regulation of cardiac specific nkx2.5 gene activity by small ubiquitin-like modifier.

Authors:  Jun Wang; Hua Zhang; Dinakar Iyer; Xin-Hua Feng; Robert J Schwartz
Journal:  J Biol Chem       Date:  2008-06-24       Impact factor: 5.157

8.  The small ubiquitin-like modifier (SUMO) is required for gonadal and uterine-vulval morphogenesis in Caenorhabditis elegans.

Authors:  Limor Broday; Irina Kolotuev; Christine Didier; Anindita Bhoumik; Bhagwati P Gupta; Paul W Sternberg; Benjamin Podbilewicz; Ze'ev Ronai
Journal:  Genes Dev       Date:  2004-10-01       Impact factor: 11.361

9.  Elevated level of SUMOylated IRF-1 in tumor cells interferes with IRF-1-mediated apoptosis.

Authors:  Junsoo Park; Kwangsoo Kim; Eun-Ju Lee; Yun-Jee Seo; Si-Nae Lim; Kyoungsook Park; Seung Bae Rho; Seung-Hoon Lee; Je-Ho Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-17       Impact factor: 11.205

10.  Formation of nuclear foci of the herpes simplex virus type 1 regulatory protein ICP4 at early times of infection: localization, dynamics, recruitment of ICP27, and evidence for the de novo induction of ND10-like complexes.

Authors:  Roger D Everett; George Sourvinos; Claire Leiper; J Barklie Clements; Anne Orr
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.